Postoperative nausea and vomiting after endoscopic thyroidectomy: total intravenous vs. balanced anesthesia by Kim, Gunn Hee et al.
Korean J Anesthesiol 2011 June 60(6): 416-421 
DOI: 10.4097/kjae.2011.60.6.416  Clinical Research Article
Copyright ⓒ the Korean Society of Anesthesiologists, 2011 www.ekja.org
Background: Endoscopic thyroidectomy was recently introduced and has been rapidly accepted by surgeons 
and patients. The present study was conducted to estimate and compare the incidences of postoperative nausea 
and vomiting (PONV) after endoscopic thyroidectomy using two different anesthetic methods: sevoflurane based 
balanced anesthesia; total intravenous anesthesia (TIVA). 
Methods: Ninety nine female patients that were scheduled to undergo elective endoscopic thyroidectomy under 
general anesthesia were enrolled. These patients were randomly allocated to receive sevoflurane based balanced 
anesthesia (BA group) or propofol-remifentanil anesthesia (TIVA group). PONV was evaluated using a 4-point Likert 
scale, and pain using a visual analogue scale (VAS; range 0 to 100) for 0-2, 2-6, and 6-24 hours postoperatively. At 
24 hours postoperatively, overall patient satisfaction regarding PONV and pain were recorded. 
Results: The incidence of PONV was 14.6% in the TIVA group and 51.3% in the BA group. The incidence of nausea 
at 0-2 and 2-6 hours postoperatively was lower in the TIVA group than in the BA group (4.2% vs. 35.9%, 6.3% vs. 
23.1%, respectively), but no between-group difference was observed at 6-24 hours postoperatively (8.3% vs. 5.1%). 
Antiemetic usage at 0-2 and 2-6 hours was lower in the TIVA than the BA group (4.2% vs. 38.5%, 6.3% vs. 23.1%), 
but no between-group difference was observed for 6-24 hours (6.3% vs. 7.7%). There were no differences in pain or in 
patient satisfaction.
Conclusions: After endoscopic thyroidectomy, total intravenous anesthesia with propofol-remifentanil is associated 
with less PONV during the early postoperative period (0-6 hours) than sevoflurane based balanced anesthesia.   
(Korean J Anesthesiol 2011; 60: 416-421)
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Introduction
    Postoperative nausea and vomiting (PONV) is one of the most 
distressing side effects, and thus is an important cause of patient 
dissatisfaction during the postoperative period [1]. In addition, 
PONV can lead to delayed post-anesthesia care unit (PACU) 
discharge, unanticipated hospital admission, and higher 
medical costs. Currently, the incidence of PONV is believed to 
be 25 to 73%, and the incidence of severe, intractable PONV 
to be approximately 0.2 to 8% among patients that undergo 
surgery [2-4]. 
    Endoscopic thyroidectomy has been rapidly accepted by 
surgeons and patients because of its cosmetic advantages. 
Conventional open thyroidectomy is a PONV prone surgery with 
an incidence as high as 70% [5]. However, there appears to be 
an even greater risk of PONV after endoscopic thyroidectomy, 
because younger, female patients tend to choose endoscopic 
thyroidectomy over conventional open thyroidectomy and 
because laparoscopic surgery, CO2 insufflation, and longer 
surgery and anesthesia durations also are common features of 
endoscopic thyroidectomy. All of these characteristics are risk 
factors for PONV [3,4,6,7].
    However, there have been no reports regarding PONV after 
endoscopic thyroidectomy. Thus, the present research was 
carried out to estimate the incidence of PONV after endoscopic 
thyroidectomy. In the present study, the incidence of PONV 
was compared between two anesthetic methods - sevoflurane 
based balanced anesthesia (BA) and total intravenous 
anesthesia (TIVA). In a previous open thyroidectomy study, 
propofol anesthesia was found to induce PONV less frequently 
than isoflurane anesthesia [5]. Therefore, we hypothesized that 
TIVA would show less PONV than sevoflurane based balanced 
anesthesia. 
Materials and Methods
    This prospective, double-blind, randomized study was 
approved by the Research Board at our hospital, and written 
informed consent was obtained from all patients.
    Female patients that were scheduled to undergo elective 
endoscopic thyroidectomy under general anesthesia were 
considered for this study. Patients with a history of a respiratory 
or cardiovascular disease, smoking, PONV, motion sickness and 
those that had taken an antiemetic during the 24 hours period 
before surgery were excluded. Finally, 99 patients were enrolled 
in the present study.
    Participants were randomly allocated to receive sevoflurane 
anesthesia with remifentanil co-administration (the BA group) 
or propofol-remifentanil anesthesia (the TIVA group) using a 
sealed envelope technique. Patients and designated observers 
of PONV were unaware of the anesthetic method given to any 
particular patient.
    No patient received premedication. Intraoperative monitoring 
included noninvasive blood pressure (NIBP) monitoring, elec-
tro  cardiography (ECG), pulse oximetry, and capnography. A blood 
pressure cuff was applied to the ankle to avoid disrup      ting the 
operative procedure. In the BA group, general anesthesia was 
induced using thiopental sodium 4-5 mg/kg and rocuronium 
0.9 mg/kg. After intubation, anesthesia was maintained using 
sevoflurane (1-1.5 minimum alveolar concentration (MAC)) 
in 50% O2 with air. Remifentanil was co-administered as a 
continuous infusion and titrated to maintain a mean blood 
pressure within 20% of baseline. In the TIVA group, propofol 
and remifentanil were administered to end organ con  cent-
rations of 5.0 μg/ml and 4.0 ng/ml, respectively, using a target-
controlled infusion (TCI) pump (Orchestra
Ⓡ, Fresenius Vial, 
France). Rocuronium 0.9 mg/kg was administered to facilitate 
intubation. Propofol and remifentanil infusions were titrated to 
maintain a mean blood pressure within 20% of baseline during 
anesthesia. O2 and air were administered in a 1 : 1 ratio.
    All endoscopic thyroidectomies were performed by two 
experienced surgeons using the bilateral axillo-breast approach 
(BABA) with patients in the supine position with neck extension 
using a shoulder pillow [8]. Before making the skin incision, 150-
200 ml of a 1 : 200,000 epinephrine solution was injected into the 
subcutaneous space in both breasts and in the subplatysmal 
space in the neck to reduce bleeding during dissection. After 
making 2 incisions on both upper circumareolar areas, subcu-
taneous and subplatysmal dissections were performed bluntly 
using a Rochester clamp and vascular tunneler. A 12-mm trocar 
was then placed ipsilateral to the thyroid mass to introduce 
a flexible endoscope. A contralateral 12-mm port was used 
for the operational instruments, which included a Harmonic 
scalpel. Carbon dioxide was then insufflated using a continuous 
pressure of 5-6 mmHg to prevent subcutaneous emphysema 
and reduce any minor bleeding. 
    Before the end of surgery, meperidine 0.5 mg/kg was injected 
for postoperative pain control and neuromuscular relaxation 
was reversed with pyridostigmine 15 mg and glycopyro-
phosphate 0.4 mg in both groups. All patients were transferred 
to the PACU. 
    Blood pressures, SpO2 and EtCO2 values, end expiratory 
sevoflurane concentrations, end organ concentrations of 
remifentanil and propofol, and peak inspiratory pressures were 
recorded at baseline, 1 minute after intubation, just after CO2 
insufflation, and subsequently at 10 minute intervals until the 
end of the procedures. Amount of intraoperative fluid, urine 
output, total amount of remifentanil and propofol, duration of 
anesthesia and duration of the procedure was also recorded. 
    A trained investigator visited each patient at 2, 6, and 24 hours 418 www.ekja.org
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postoperatively, and checked the occurrence and severity of 
PONV. Nausea was defined as the sensation of having the urge 
to vomit, and was graded using a 4-point Likert scale (0 = none, 
1 = mild, 2 = moderate, 3 = severe). Vomiting was defined as the 
forceful evacuation of stomach contents. Ondansetron 4 mg 
or metoclopropamide 10 mg was administered after a patient 
vomited or when a patient requested an antiemetic; and these 
instances of drug administration were recorded.
    Pain was evaluated at 2, 6, and 24 hours postoperatively using 
a visual analogue scale (VAS; range 0 to 100). If VAS was higher 
than 50 or a patient requested pain medication, ketorolac 30 mg 
was injected, and if this was ineffective, meperidine 0.5 mg/kg 
was added. 
    At 24 hours postoperatively, overall patient satisfaction 
regarding the treatment of PONV and pain were recorded as 
very good, good, fair, bad, or poor.
Statistics
    No report has been previously issued regarding the incidence 
of PONV after endoscopic thyroidectomy. However, the 
incidence of PONV after isoflurane anesthesia and propofol 
anesthesia for open thyroidectomy have been reported to be 
47% and 24%, respectively [9]. Therefore, we considered a 30% 
reduction of PONV in the TIVA group versus the BA group 
as significant. To identify this 30% reduction with an alpha 
error of 0.05 and a power of 80%, the required sample size 
was calculated to be 39 per group. Initially, 99 patients were 
included in the study, assuming a dropout rate of 20%, and 87 
completed the study (39 in the BA group, 48 in the TIVA group). 
    PONV and pain at 2, 6, and 24 hours postoperative were 
compared using the Mann-Whitney U-test or the Chi-square 
test. Statistical significance was accepted for P values of < 0.05. 
Results
    Twelve of 99 patients were excluded from the analysis. In two, 
the operation method was changed to open thyroidectomy, in 
three, the anesthetic method was altered, and the other seven 
were excluded due to incomplete data. Therefore, the data of 87 
patients were analyzed, 39 in the BA group and 48 patients in 
the TIVA group.
    Age, weight, height, and ASA physical status were not 
significantly different in the two study groups. However, 
duration of surgery and anesthesia was longer in the TIVA group, 
differences which appeared to have been caused by a greater 
proportion of total thyroidectomy cases in the TIVA group (total 
thyroidectomy: 54.2% vs. 35.9%, hemithyroidectomy: 45.8% vs. 
64.1%, in the TIVA and BA groups, respectively, P = 0.130). Total 
remifentanil used during surgery was greater in the TIVA group 
than in the BA group (Table 1). 
    Systolic blood pressure (SBP) and heart rate at baseline 
were not significantly different between the two groups. SBP 
was significantly higher at 1 minute after intubation, but was 
maintained at a lower level during the operation in the BA 
Table 1. Characteristics of Patients and Anesthesia 
TIVA group
(n = 48)
BA group
(n = 39)
P
Age (yr)
Weight (kg)
Height (cm)
ASA
Crystalloid (ml)
Duration of operation (min)
Duration of anesthesia (min)
Total remifentanil (mg)
Total propofol (g)
40.0 ± 9.7
56.6 ± 8.3
158.9 ± 5.8
1
875 (675-1,425)
143 (119-177)
195 (157-232)
1.8 (1.45-2.28)
1.8 (1.52-2.0)
38.9 ± 8.8
57.7 ± 6.6
158.6 ± 3.6
1
600 (500-737)
100 (90-120)
150 (130-160)
0.6 (0.43-1.0)
0
NS
NS
NS
NS
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
Values are means ± SDs or medians (25-75% interquartile ranges). ASA: American society of anesthesiologists physical status.
Fig. 1. Systolic blood pressure and heart rate for the TIVA and BA 
groups. SBP: systolic blood pressure, HR: heart rate. *P < 0.05 
between the groups.419 www.ekja.org
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group than in the TIVA group, and heart rate (HR) from the time 
of intubation to the end of surgery was significantly greater in 
the BA group (Fig. 1).
    No significant difference in end-tidal CO2 (TIVA group = 
33.0 ± 6.8 mmHg vs. the BA group = 32.6 ± 4.4 mmHg) or peak 
inspiratory pressure (the TIVA group = 17.9 ± 9.4 cm H2O vs. 
the BA group = 18 ± 9.4 cm H2O) was observed between the two 
groups.
    The overall incidence of PONV was 14.6% and 51.3% in the 
TIVA and BA groups (P < 0.05). The incidence of nausea was 
significantly lower in the TIVA group than in the BA group at 
0-2 and 2-6 hours postoperatively (0-2 hours: 4.2% vs. 35.9%, 
2-6 hours: 6.3% vs. 23.1%) but not at 6-24 hours post  operati-
vely (8.3% vs. 5.1%, in the TIVA and BA groups, respectively). 
Antiemetic use showed a similar trend. No significant difference 
was observed between the two groups in terms of the incidence 
of vomiting at any postoperative time point (Table 2).
    The severity of nausea, as measured using a 4-point Likert 
scale, showed that mild nausea predominated. The prevalence 
of mild nausea in the TIVA and BA groups was: 4.2% vs. 23.1% 
at 0-2 hours, 6.2% vs. 20.5% at 2-6 hours, and 6.2% vs. 5.1% 
at 6-24 hours, respectively (P > 0.05). The prevalence of 
moderate and severe nausea were, in the TIVA and BA groups, 
respectively: 0% vs. 12.8% at 0-2 hours, 0% vs. 2.6% at 2-6 
hours, and 2.1% vs. 0% at 6-24 hours (P > 0.05).
    VAS scores and analgesic use were not significantly different 
in the two study groups (Table 3); neither was time spent in the 
PACU (66 ± 9 min for the TIVA group; 67 ± 12 min for the BA 
group ).
    In both groups, almost all patients were satisfied with the 
treatment of PONV and pain (Table 4).
Discussion
    The incidence of PONV during the first 24 postoperative 
hours after endoscopic thyroidectomy were 14.6% and 51.3% 
in the TIVA and BA groups, respectively. The type of anesthesia 
was found to influence PONV significantly during the early 
postoperative period (0-6 hours), but not subsequently. 
    When we initiated this study, we anticipated a higher 
incidence of PONV after endoscopic thyroidectomy than that 
associated with open thyroidectomy. In particular, because 
laparoscopy with CO2 insufflation is known to increase PONV 
[10,11], it has been suggested that the etiology of PONV after 
laparoscopy is due to residual stretching and irritation of the 
peritoneum [10] or to the dilation of cerebral vessels and an 
increase in intracranial pressure (ICP) caused by the CO2 [11]. 
However, the incidence of PONV observed during the present 
study was similar to that reported for open thyroidectomy 
(~50%) for inhalation groups. In the case of propofol 
anesthesia, the PONV incidence was even lower (14.6%) than 
that after open thyroidectomy (24%)[9]. During endoscopic 
thyroidectomy, CO2 is applied between subcutaneous tissue 
and muscles rather than intraperitoneally, and the insufflation 
pressure is usually limited to 5-6 mmHg instead of 12 mmHg 
to avoid acidosis or adverse haemodynamic changes [10-12]. 
In addition, we modulated tidal volume and respiratory rate to 
maintain an EtCO2 of 35-45 mmHg, and therefore, the effect 
Table 2. Incidence of PONV and Antiemetics 
TIVA group
( n = 48 )
BA group
( n = 39)
P
Nausea
    0-2 hr
    2-6 hr
    6-24 hr
    Total
Vomiting
    0-2 hr
    2-6 hr
    6-24 hr
    Total
PONV
    0-2 hr
    2-6 hr
    6-24 hr
    Total
Antiemetics
    0-2 hr
    2-6 hr
    6-24 hr
2 (4.2)
3 (6.3)
4 (8.3)
7 (14.6)
0
2 (4.2)
2 (4.2)
3 (6.3)
2 (4.2)
3 (6.3)
3 (6.3)
7 (14.6)
2 (4.2)
3 (6.3)
5 (10.4)
14 (35.9)
9 (23.1)
2 (5.1)
20 (51.3)
2 (5.1)
0
2 (5.1)
3 (7.7)
15 (38.5)
9 (23.1)
3 (7.7)
20 (51.3)
10 (25.6)
8 (20.5)
3 (7.7)
< 0.0001
0.031
NS
< 0.0001
NS
NS
NS
NS
< 0.0001
0.031
NS
< 0.0001
0.005
0.058
NS
Values are number of patients (%).
Table 3. Pain and Analgesics 
TIVA group
(n = 48)
BA group
(n = 39)
P
VAS score
    0-2 hr
    2-6 hr
    6-24 hr
Analgesics n (%)
    0-2 hr
    2-6 hr
    6-24 hr
50 (31-70)
30 (20-40)
20 (10-30)
44 (91.7)
22 (45.8)
25 (52.1)
50 (40-70)
30 (12.5-40)
20 (10-20)
38 (97.4)
25 (64.1)
24 (61.5)
NS
NS
NS
NS
NS
NS
Values are medians (25-75% interquartile ranges) or numbers of 
patients (%). VAS: visual analogue scale.
Table 4. Overall Patient Satisfaction with Treatment for PONV and 
Pain 
Very good Good Fair Bad Poor
TIVA group
BA group
16 (33.3)
16 (41.0)
30 (62.5)
22 (56.4)
1 (2.1)
1 (2.6)
1 (2.1)
0
0
0
Values are numbers of patients (%). No differences were observed 
between the two study groups.420 www.ekja.org
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of CO2 insufflation on PONV after endoscopic thyroidectomy 
might not be as great as after laparoscopy. Further studies are 
required to compare open and endoscopic thyroidectomy with 
respect to the incidence of PONV. 
    The primary end point of our study was the incidence of 
PONV between the BA and TIVA groups. In previous open 
thyroidectomy studies, propofol anesthesia was found to 
reduce the incidence of PONV as compared with inhalational 
anesthesia [5,9]. Gauger and colleagues also found that PONV 
was significantly less likely in a propofol group during the early 
period (in the operating room and postanesthesia care unit) 
but not at later times (postoperative day 1 or 2) [9]. The results 
of these two open thyroidectomy studies are in line with the 
results of our endoscopic thyroidectomy study. In our study, 
the early postoperative PONV incidence was lower in the TIVA 
group than in the BA group.
    Propofol is known to have an antiemetic effect, and the use 
of propofol during balanced or total intravenous anesthesia 
had been reported to significantly reduce the incidence of 
opioid-induced nausea and vomiting [13]. Some authors have 
reported that propofol used as a maintenance anesthetic during 
breast surgery is more effective than 4 mg of ondansetron given 
as prophylaxis in terms of preventing PONV [14]. The exact 
mechanism underlying the antiemetic effect of propofol has not 
been determined, but it has been reported that propofol does 
not interact strongly with D2 dopamine receptors [15]. 
    In the present study, a greater amount of remifentanil was 
administered in the TIVA group, but the incidence of PONV 
was much lower in this group than in the BA group. Although 
chemically related to fentanyl congeners, remifentanil is 
structurally unique because of its ester linkages. This ester 
group in remifentanil renders it susceptible to hydrolysis by 
blood and tissue nonspecific esterases. which results in its rapid 
metabolism and a reduction in its blood concentrations after 
infusion is terminated [16,17]. Therefore, the higher amount of 
remifentanil administered in the TIVA group might not have 
increased PONV due to its rapid elimination.
    Other factors that are known to influence PONV, such as 
pain and postoperative analgesic consumption, did not differ 
between the two study groups. Furthermore, operation and 
anesthesia duration, which are known to influence PONV, were 
greater in the TIVA group. Thus, had operation and anesthesia 
duration been similar, the two groups would probably have 
differed more in terms of PONV.
    In the present study, the volume of infused crystalloid 
solution was greater in the TIVA group. This was because the 
TIVA group had a longer operating time than the BA group. 
The impact of the volume of crystalloid on PONV is not well 
defined. In a recent study, Dagher et al. failed to observe any 
benefit of rapid infusion of 30 ml/kg over 10 ml/kg of crystalloid 
solution in reducing the incidence of PONV after thyroidectomy 
[18]. Therefore, the difference in volume of crystalloid solution 
probably had no effect on PONV in either group. 
    In the present study, the incidence of vomiting was not different 
between the two groups, which may have been because we 
administered antiemetics as soon as patients complained of 
nausea or requested antiemetics, and the incidence of antie-
metic administration was significantly higher in the BA group. 
    The TIVA group was found to have higher systolic blood 
pressure than the BA group during the operation. It has been 
reported that during laparoscopic oophorectomy, more stress 
hormones are released during TIVA anesthesia than during 
sevoflurane anesthesia [19], and thus, the higher stress hormone 
levels observed in the TIVA group could explain the higher 
systolic pressure. Alternatively, the higher SBP could have been 
due to the fact that 150-200 ml of 1 : 200,000 epinephrine 
is routinely infiltrated during endoscopic thyroidectomy, 
and the long lasting hemodynamic effect of slowly absorbed 
epinephrine might not have been counterbalanced as effecti-
vely as sevoflurane during TIVA. Propofol is administered in 
much lower doses when co-administered with remifentanil. 
Opioids have fewer cardiovascular effects than many other 
intravenous and inhaled anesthetics. Furthermore, opioids 
reverses blood pressure elevation mainly by suppressing the 
central release of stress hormones, and, therefore, they have 
little ability to antagonize externally administered epinephrine 
[20]. Further detailed comparative studies on hemodynamic 
changes during endoscopic thyroidectomy associated with BA 
and TIVA are required. 
    In conclusion, the present study shows that the incidence 
of PONV after sevoflurane-based balanced anesthesia during 
endoscopic thyroidectomy is as high as 50%. TIVA with 
propofol-remifentanil was found to reduce the incidence 
of PONV to 15% and its antiemetic effect was found to be 
maintained for 6 hours after surgery.
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